Melatonin regulates the autophagic flux via activation of alpha-7 nicotinic acetylcholine receptors

Journal of Pineal Research

Volumn 59, Issue 1, 2015, Pages 24-37

  Jeong, Jae Kyo ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

alpha 7 nicotinic receptor; autophagy flux; melatonin; prion

Indexed keywords

4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; BUNGAROTOXIN RECEPTOR; CASPASE 3; MELATONIN; PROTEIN P62; NEUROPROTECTIVE AGENT; NICOTINIC RECEPTOR;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL COUNT; CELL DAMAGE; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRION; PROTEIN FUNCTION; TUNEL ASSAY; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

AUTOPHAGY; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MELATONIN; NEUROPROTECTIVE AGENTS; RECEPTORS, NICOTINIC; RNA INTERFERENCE;

EID: 84934277131     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12235     Document Type: Article

References (69)

1. Stehle JH, Saade A, Rawashdeh O, et al., A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
2. Huether G,. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 1993; 49: 665-670.
3. Acuna-Castroviejo D, Escames G, Venegas C, et al., Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 2014; 71: 2997-3025.
4. Jenwitheesuk A, Nopparat C, Mukda S, et al., Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci 2014; 15: 16848-16884.
5. Calvo JR, Gonzalez-Yanes C, Maldonado MD,. The role of melatonin in the cells of the innate immunity: a review. J Pineal Res 2013; 55: 103-120.
6. Guerrero JM, Reiter RJ,. Melatonin-immune system relationships. Curr Top Med Chem 2002; 2: 167-179.
7. Glaser S, Han Y, Francis H, et al., Melatonin regulation of biliary functions. Hepatobiliary Surg Nutr 2014; 3: 35-43.
8. Bubenik GA,. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10: 350-366.
9. Hardeland R, Poeggeler B,. Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system. Cent Nerv Syst Agents Med Chem 2012; 12: 189-216.
10. Liu XJ, Yuan L, Yang D, et al., Melatonin protects against amyloid-beta-induced impairments of hippocampal LTP and spatial learning in rats. Synapse 2013; 67: 626-636.
11. Herrera EA, Macchiavello R, Montt C, et al., Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs. J Pineal Res 2014; 57: 33-42.
12. Ozacmak VH, Barut F, Ozacmak HS,. Melatonin provides neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats. J Pineal Res 2009; 47: 156-163.
13. Garcia-Santos G, Antolin I, Herrera F, et al., Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006; 41: 130-135.
14. Jeong J-K, Moon M-H, Lee Y-J, et al., Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res 2012; 53: 138-146.
15. Dragicevic N, Copes N, O'Neal-moffitt G, et al., Melatonin treatment restores mitochondrial function in alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 2011; 51: 75-86.
16. Ali T, Badshah H, Kim TH, et al., Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-KB/JNK signaling pathway in aging mouse model. J Pineal Res 2015; 58: 71-85.
17. Yu L, Sun Y, Cheng L, et al., Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1. J Pineal Res 2014; 57: 228-238.
18. Carloni S, Albertini MC, Galluzzi L, et al., Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia. J Pineal Res 2014; 57: 192-199.
19. Yang Y, Jiang S, Dong Y, et al., Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice. J Pineal Res 2015; 58: 61-70.
20. Prusiner SB,. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-13383.
21. Wickner RB,. Prion diseases: infectivity versus toxicity. Nature 2011; 470: 470-471.
22. Freixes M, Rodriguez A, Dalfo E, et al., Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in creutzfeldt-jakob disease. Neurobiol Aging 2006; 27: 1807-1815.
23. Avrahami D, Gabizon R,. Age-related alterations affect the susceptibility of mice to prion infection. Neurobiol Aging 2011; 32: 2006-2015.
24. Hara H, Okemoto-Nakamura Y, Shinkai-Ouchi F, et al., Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrPC to PrPSc in prion-infected neuroblastoma cells. J Virol 2012; 86: 5626-5636.
25. Siskova Z, Mahad DJ, Pudney C, et al., Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease. Am J Pathol 2010; 177: 1411-1421.
26. Devi L, Prabhu BM, Galati DF, et al., Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 2006; 26: 9057-9068.
27. Jeong JK, Seo JS, Moon MH, et al., Hypoxia-inducible factor-1 alpha regulates prion protein expression to protect against neuron cell damage. Neurobiol Aging 2012; 33: 1006.e1001-1010.
28. Jeong J-K, Moon M-H, Lee Y-J, et al., Autophagy induced by the class III histone deacetylase sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging 2013; 34: 146-156.
29. Jeong J-K, Moon M-H, Bae B-C, et al., Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity. Neurosci Res 2012; 73: 99-105.
30. Choi SI, Kim KS, Oh JY, et al., Melatonin induces autophagy via an mTOR-dependent pathway and enhances clearance of mutant-TGFBIp. J Pineal Res 2013; 54: 361-372.
31. Hong Y, Won J, Lee Y, et al., Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J Pineal Res 2014; 56: 264-274.
32. Chen J, Wang L, Wu C, et al., Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J Pineal Res 2014; 56: 12-19.
33. Bizargity P, Schroppel B,. Autophagy: basic principles and relevance to transplant immunity. Am J Transplant 2014; 14: 1731-1739.
34. Slobodkin MR, Elazar Z,. The atg8 family: multifunctional ubiquitin-like key regulators of autophagy. Essays Biochem 2013; 55: 51-64.
35. Svenning S, Johansen T,. Selective autophagy. Essays Biochem 2013; 55: 79-92.
36. Rogov V, Dotsch V, Johansen T, et al., Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Biomed Res Int 2014; 53: 167-178.
37. Lippai M, Low P,. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int 2014; 2014: 832704.
38. Orhon I, Dupont N, Pampliega O, et al., Autophagy and regulation of cilia function and assembly. Cell Death Differ 2015; 22: 389-397.
39. Ishii T, Warabi E, Siow RC, et al., Sequestosome1/p62: a regulator of redox-sensitive voltage-activated potassium channels, arterial remodeling, inflammation, and neurite outgrowth. Free Radic Biol Med 2013; 65: 102-116.
40. Komatsu M, Kageyama S, Ichimura Y,. p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 2012; 66: 457-462.
41. Lin X, Li S, Zhao Y, et al., Interaction domains of p62: a bridge between p62 and selective autophagy. DNA Cell Biol 2013; 32: 220-227.
42. Mizumura K, Choi AM, Ryter SW,. Emerging role of selective autophagy in human diseases. Front Pharmacol 2014; 5: 244.
43. Buckley KM, Hess DL, Sazonova IY, et al., Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Exp Transl Stroke Med 2014; 6: 8.
44. Hung SY, Huang WP, Liou HC, et al., Autophagy protects neuron from Abeta-induced cytotoxicity. Autophagy 2009; 5: 502-510.
45. Young JW, Geyer MA,. Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochem Pharmacol 2013; 86: 1122-1132.
46. Ahnallen CG,. The role of the alpha7 nicotinic receptor in cognitive processing of persons with schizophrenia. Curr Opin Psychiatry 2012; 25: 103-108.
47. Albuquerque EX, Pereira EF, Castro NG, et al., Nicotinic receptor function in the mammalian central nervous system. Ann N Y Acad Sci 1995; 757: 48-72.
48. Niranjan R, Nath C, Shukla R,. Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6. Free Radic Res 2012; 46: 1167-1177.
49. Parada E, Buendia I, Leon R, et al., Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression. J Pineal Res 2014; 56: 204-212.
50. Stuckenholz V, Bacher M, Balzer-Geldsetzer M, et al., The alpha7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice. J Parkinsons Dis 2013; 3: 161-172.
51. Di Paolo T, Goire L, Feuerbach D, et al., AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. Parkinsonism Relat Disord 2014; 20: 1119-1123.
52. Thomsen MS, Hansen HH, Timmerman DB, et al., Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 2010; 16: 323-343.
53. Hernandez CM, Kayed R, Zheng H, et al., Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of alzheimer's disease. J Neurosci 2010; 30: 2442-2453.
54. Araya JA, Ramirez AE, Figueroa-Aroca D, et al., Modulation of neuronal nicotinic receptor by quinolizidine alkaloids causes neuroprotection on a cellular alzheimer model. J Alzheimers Dis 2014; 42: 143-155.
55. Hu M, Waring JF, Gopalakrishnan M, et al., Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells. J Neurochem 2008; 106: 1371-1377.
56. Bordia T, McGregor M, Papke RL, et al., The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions. Exp Neurol 2015; 263: 277-284.
57. Kawamata J, Shimohama S,. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of alzheimer's and Parkinson's diseases. J Alzheimers Dis 2011; 24 (Suppl 2): 95-109.
58. Yamamoto A, Yue Z,. Autophagy and its normal and pathogenic states in the brain. Annu Rev Neurosci 2014; 37: 55-78.
59. Vidal RL, Matus S, Bargsted L, et al., Targeting autophagy in neurodegenerative diseases. Trends Pharmacol Sci 2014; 35: 583-591.
60. Ryter SW, Koo JK, Choi AM,. Molecular regulation of autophagy and its implications for metabolic diseases. Curr Opin Clin Nutr Metab Care 2014; 17: 329-337.
61. Nishida K, Taneike M, Otsu K,. The role of autophagic degradation in the heart. J Mol Cell Cardiol 2015; 78: 73-79.
62. Yamaguchi O, Otsu K,. Role of autophagy in aging. J Cardiovasc Pharmacol 2012; 60: 242-247.
63. Speakman JR, Mitchell SE,. Caloric restriction. Mol Aspects Med 2011; 32: 159-221.
64. Hartman AL,. Neuroprotection in metabolism-based therapy. Epilepsy Res 2012; 100: 286-294.
65. Dinkins C, Pilli M, Kehrl JH,. Roles of autophagy in HIV infection. Immunol Cell Biol 2015; 93: 11-17.
66. Choi J, Ravipati A, Nimmagadda V, et al., Potential roles of PINK1 for increased PGC-1alpha-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes. Mitochondrion 2014; 18c: 41-48.
67. Jeong JK, Moon MH, Park YG, et al., Gingerol-induced hypoxia-inducible factor 1 alpha inhibits human prion peptide-mediated neurotoxicity. Phytother Res 2013; 27: 1185-1192.
68. Kazlauskaite A, Muqit MMK,. PINK1 and Parkin-mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease. FEBS J 2015; 282: 215-223.
69. Yu W, Mechawar N, Krantic S, et al., alpha7 Nicotinic receptor activation reduces beta-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. J Neurochem 2011; 119: 848-858.